$KPTI Two Major Event Set For 4Q21 P2/3 Top-Line - Selinexor (Endometrial Cancer) - SIENDO CHMP Opinion - Selinexor Triplet (Multiple Myeloma) (Triplet Already Approved in the US) Plenty of Cash: $233.6M as of MAR 31, 2021
2
2
2 Likes